Skip to main content

Featured

Europe at a Crossroads: Trump’s Stark Warning in Davos

                                              A lit up sign put up over Davos ahead of President Trumps arrival At the World Economic Forum in Davos, President Donald Trump delivered a pointed critique of Europe’s current trajectory, arguing that the continent is “heading in the wrong direction.” His remarks added a sharper edge to a summit already defined by global uncertainty and competing visions for the future. Trump’s comments focused on what he described as Europe’s economic stagnation, political fragmentation, and policy choices around migration and energy. He suggested that these decisions were weakening Europe’s long‑term stability and diminishing its global influence. Framing the issue in broader terms, he emphasized that global prosperity is closely tied to American economic strength, asserting that a strong United States remains essent...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment